A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
暂无分享,去创建一个
Philippe Hantraye | Olivier Marre | Serge Picaud | José-Alain Sahel | Elena Brazhnikova | Jens Duebel | Deniz Dalkara | Romain Caplette | Antoine Chaffiol | Alexis-Pierre Bemelmans | Ernst Bamberg | O. Marre | E. Bamberg | J. Sahel | S. Picaud | C. Jaillard | D. Dalkara | A. Bemelmans | E. Dubus | P. Hantraye | A. Chaffiol | J. Duebel | P. Benoit | Emilie Macé | Mélissa Desrosiers | E. Brazhnikova | Céline Jaillard | Elisabeth Dubus | Laëtitia Duhamel | Patrick Benoit | Laetitia Duhamel | M. Desrosiers | R. Caplette | Emilie Mace | Jens Duebel | É. Dubus
[1] Kathleen A. Marshall,et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[2] Michael H Berry,et al. Optogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] E. Turner,et al. Brn3a-Expressing Retinal Ganglion Cells Project Specifically to Thalamocortical and Collicular Visual Pathways , 2005, The Journal of Neuroscience.
[4] Olivier Marre,et al. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] Jean Bennett,et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial , 2016, The Lancet.
[6] Jessy D. Dorn,et al. Interim results from the international trial of Second Sight's visual prosthesis. , 2012, Ophthalmology.
[7] V. Choi,et al. Production of Recombinant Adeno‐Associated Viral Vectors , 1999, Current protocols in human genetics.
[8] Volker Busskamp,et al. Optogenetic approaches to restoring visual function in retinitis pigmentosa , 2011, Current Opinion in Neurobiology.
[9] Edwin M Stone,et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics , 2008, Proceedings of the National Academy of Sciences.
[10] G. Veres,et al. Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] T. Léveillard,et al. Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration. , 2015, The Journal of clinical investigation.
[12] Annette E. Allen,et al. Restoration of Vision with Ectopic Expression of Human Rod Opsin , 2015, Current Biology.
[13] A. Cideciyan,et al. Retinal optogenetic therapies: clinical criteria for candidacy , 2013, Clinical genetics.
[14] Michael J. Castle,et al. Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey , 2011, Science Translational Medicine.
[15] J. Flannery,et al. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates , 2014, Gene Therapy.
[16] Dirk Trauner,et al. LiGluR restores visual responses in rodent models of inherited blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] David R Williams,et al. Intravitreal injection of AAV2 transduces macaque inner retina. , 2011, Investigative ophthalmology & visual science.
[18] Edward S Boyden,et al. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] M Tamai,et al. Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy , 2011, Gene Therapy.
[20] Edward S Boyden,et al. A gene-fusion strategy for stoichiometric and co-localized expression of light-gated membrane proteins , 2011, Nature Methods.
[21] Deniz Dalkara,et al. In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous , 2013, Science Translational Medicine.
[22] Siegrid Löwel,et al. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool , 2015, PLoS biology.
[23] Shomi S. Bhattacharya,et al. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait , 2010, Nature Reviews Genetics.
[24] Karl Deisseroth,et al. Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa , 2010, Science.
[25] A. Sher,et al. Photovoltaic restoration of sight with high visual acuity , 2015, Nature Medicine.
[26] F. Cremers,et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.
[27] Douglas A Jabs,et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.
[28] V. Choi,et al. Production of Recombinant Adeno‐Associated Viral Vectors for In Vitro and In Vivo Use , 2007, Current protocols in molecular biology.
[29] Nick Tyler,et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[30] R. Ali,et al. Molecular genetics and prospects for therapy of the inherited retinal dystrophies. , 2001, Current opinion in genetics & development.
[31] Stefan R. Pulver,et al. Independent Optical Excitation of Distinct Neural Populations , 2014, Nature Methods.
[32] F. Werblin,et al. Differential Targeting of Optical Neuromodulators to Ganglion Cell Soma and Dendrites Allows Dynamic Control of Center-Surround Antagonism , 2011, Neuron.
[33] E. Bamberg,et al. Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh , 2011, Nature Neuroscience.
[34] Eriko Sugano,et al. Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. , 2010, Experimental eye research.
[35] J. Goldberg,et al. γ-Synuclein as a marker of retinal ganglion cells , 2008, Molecular vision.
[36] E. Bamberg,et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Milam,et al. Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa. , 1999, Investigative ophthalmology & visual science.
[38] Olivier Marre,et al. Red‐shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina , 2016, EMBO molecular medicine.
[39] W. Feuer,et al. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. , 2016, Ophthalmology.
[40] Kathleen A. Marshall,et al. AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness , 2012, Science Translational Medicine.
[41] Douglas S Kim,et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration , 2008, Nature Neuroscience.
[42] T. Aleman,et al. Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina. , 2017, Human gene therapy.
[43] Eriko Sugano,et al. Restoration of the Majority of the Visual Spectrum by Using Modified Volvox Channelrhodopsin-1 , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] D. Kleinfeld,et al. ReaChR: A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation , 2013, Nature Neuroscience.
[45] David A. Leopold,et al. Brains, Genes, and Primates , 2015, Neuron.
[46] Jessica A. Cardin,et al. Noninvasive optical inhibition with a red-shifted microbial rhodopsin , 2014, Nature Neuroscience.
[47] Zhuo-Hua Pan,et al. Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. , 2010, Investigative ophthalmology & visual science.
[48] David Williams,et al. Imaging Light Responses of Foveal Ganglion Cells in the Living Macaque Eye , 2014, The Journal of Neuroscience.
[49] Riccardo Storchi,et al. Melanopsin Contributions to the Representation of Images in the Early Visual System , 2017, Current Biology.
[50] S. Seregard,et al. Photochemical damage of the retina. , 2006, Survey of ophthalmology.
[51] A. Baiker,et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. , 2012, Human gene therapy methods.
[52] Tushar H. Ganjawala,et al. ChR2 Mutants at L132 and T159 with Improved Operational Light Sensitivity for Vision Restoration , 2014, PloS one.
[53] John G. Flannery,et al. Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells , 2014, Proceedings of the National Academy of Sciences.
[54] A. Dizhoor,et al. Ectopic Expression of a Microbial-Type Rhodopsin Restores Visual Responses in Mice with Photoreceptor Degeneration , 2006, Neuron.
[55] R. Nussenblatt,et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. , 1985, Ophthalmology.